Page last updated: 2024-10-18

dalteparin and Bernhardt-Roth Syndrome

dalteparin has been researched along with Bernhardt-Roth Syndrome in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"We report a case of femoral nerve palsy occurring as a result of spontaneous bilateral iliopsoas haematomas in an elderly patient on treatment dose dalteparin for a suspected pulmonary embolus."3.83Femoral nerve palsy associated with bilateral spontaneous iliopsoas haematomas: a complication of venous thromboembolism therapy. ( Kent, M; Podger, H, 2016)
"BACKGROUND Femoral neuropathy as a result of retroperitoneal hemorrhage most commonly occurs following pelvic and lower extremity trauma, but has been described to develop as a less frequent complication of anticoagulation."1.46Bilateral Femoral Neuropathy Following Psoas Muscle Hematomas Caused by Enoxaparin Therapy. ( Akkad, I; Bhardwaj, S; Demir, S; Kakar, P; Macauley, P; Shankar, S; Soni, P, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Macauley, P1
Soni, P1
Akkad, I1
Demir, S1
Shankar, S1
Kakar, P1
Bhardwaj, S1
Podger, H1
Kent, M1

Other Studies

2 other studies available for dalteparin and Bernhardt-Roth Syndrome

ArticleYear
Bilateral Femoral Neuropathy Following Psoas Muscle Hematomas Caused by Enoxaparin Therapy.
    The American journal of case reports, 2017, Aug-29, Volume: 18

    Topics: Anticoagulants; Enoxaparin; Female; Femoral Neuropathy; Hematoma; Humans; Middle Aged; Psoas Muscles

2017
Femoral nerve palsy associated with bilateral spontaneous iliopsoas haematomas: a complication of venous thromboembolism therapy.
    Age and ageing, 2016, Volume: 45, Issue:1

    Topics: Aged, 80 and over; Anticoagulants; Dalteparin; Female; Femoral Neuropathy; Hematoma; Humans; Magneti

2016